{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "epsTrailingTwelveMonths": -2.55, "sharesOutstanding": 2254000, "bookValue": 0.667, "fiftyDayAverage": 3.5842, "fiftyDayAverageChange": 0.09580016, "fiftyDayAverageChangePercent": 0.026728464, "twoHundredDayAverage": 5.7733, "twoHundredDayAverageChange": -2.0933, "twoHundredDayAverageChangePercent": -0.36258292, "marketCap": 8573591, "priceToBook": 5.5172415, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "currency": "EUR", "financialCurrency": "PLN", "regularMarketOpen": 3.58, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.27999997, "fiftyTwoWeekLowChangePercent": 0.08235293, "fiftyTwoWeekRange": "3.4 - 10.3", "fiftyTwoWeekHighChange": -6.62, "fiftyTwoWeekHighChangePercent": -0.64271843, "fiftyTwoWeekLow": 3.4, "fiftyTwoWeekHigh": 10.3, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "firstTradeDateMilliseconds": 1545894000000, "priceHint": 4, "marketState": "REGULAR", "regularMarketChange": 0.055000067, "regularMarketTime": 1683902144, "regularMarketDayHigh": 3.675, "regularMarketDayRange": "3.58 - 3.675", "regularMarketDayLow": 3.58, "regularMarketVolume": 0, "regularMarketPreviousClose": 3.625, "bid": 3.64, "ask": 4.03, "bidSize": 0, "askSize": 0, "fullExchangeName": "Stuttgart", "regularMarketChangePercent": 1.5172433, "regularMarketPrice": 3.68, "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "esgPopulated": false, "exchange": "STU", "shortName": "Pure Biologics S.A.", "longName": "Pure Biologics Sp\u00f3lka Akcyjna", "messageBoardId": "finmb_577820719", "market": "dr_market", "symbol": "PQB.SG"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "ul. Dunska 11", "city": "Wroclaw", "zip": "54-427", "country": "Poland", "phone": "48 795 61 18 11", "website": "https://purebiologics.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Pure Biologics Sp\u00f3lka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare neurological diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurological autoimmune disorders, including neuromyelitis optica and myasthenia gravis; and provides contract research for pharmaceutical and biotechnology companies. Pure Biologics Sp\u00f3lka Akcyjna was incorporated in 2010 and is headquartered in Wroclaw, Poland.", "fullTimeEmployees": 96, "companyOfficers": [{"maxAge": 1, "name": "Dr. Filip  Jelen M.B.A., Ph.D.", "title": "Co-founder & Pres of the Management Board", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Romuald Apollo Harwas", "title": "VP of the Management Board & CFO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Pieter  Spee", "title": "VP of the Management Board & CSO", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marta  Wawrzyniak M.B.A.", "title": "Chief Operating Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Martyna  Koj", "title": "Director of the Company Office & Investor Relations Representative", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Marta  Rot", "title": "Head of HR", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Michal  Pirog", "title": "Head of the Laboratory", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Przemyslaw  Dudek", "title": "Head of Information Technology", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Ewelina  Swiderek", "title": "Head of Projects Portfolio", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Przemyslaw  Jurek M.B.A.", "title": "Chief Bus. Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "maxAge": 86400}}], "error": null}}